Andrew Freese

Title: The Innovative Contributions of Andrew Freese

Introduction

Andrew Freese is a notable inventor based in Haverford, PA (US). He has made significant strides in the field of neurological research, particularly in the treatment of diseases such as Huntington's. His work focuses on the biochemical pathways that can alleviate the toxic effects of excitatory amino acids in the brain.

Latest Patents

Freese holds a patent for the treatment of neurological diseases by increasing brain concentrations of kynurenic acid. This innovative approach addresses conditions like Huntington's Disease, which is characterized by a decrease in kynurenic acid levels in the brain. The patent outlines the administration of metabolic precursors, including kynurenine and tryptophan, to affected individuals. This method aims to inhibit the harmful interactions of excitatory amino acids at their receptors, potentially alleviating the symptoms associated with these neurological disorders. He has 1 patent to his name.

Career Highlights

Freese is affiliated with The General Hospital Corporation, where he continues to contribute to groundbreaking research in neurology. His work has implications for improving the quality of life for individuals suffering from debilitating neurological conditions.

Collaborations

Freese has collaborated with esteemed colleagues in the field, including M Flint Beal and Kenton J Swartz. Their combined expertise enhances the research efforts aimed at understanding and treating neurological diseases.

Conclusion

Andrew Freese's innovative work in the treatment of neurological diseases showcases the potential of biochemical research in improving patient outcomes. His contributions are paving the way for new therapeutic strategies in neurology.